- IPNA •
- 22 February, 2025 •
- •
Pegcetacoplan for adolescents with C3G or primary IC-MPGN: VALIANT phase 3 double-blind placebo-controlled trial subgroup analysis
Marina Vivarelli, Gema Ariceta, Yael Borovitz, Bradley P Dixon, Larry A Greenbaum, Christoph Licht, Antonio Mastrangelo, Nabil Melhem, Naoya Fujita, Nicole CAJ Van de Kar, Dean Wallace, Li Li, Luis López Lázaro, Johan Szamosi, Carla M Nester
Available materials